Kenanga IB offers world's first Hang Seng Biotech Index structured warrants


From left: Nancy Cheng, Executive Director and Head of Operations of Hang Seng Indexes Company; Linda Luk, Executive Director and Product Strategist (ETF); Gilbert Lee, Executive Chairman; Nicholas Ho, Commissioner for Belt and Road of the HKSAR Government; Muzambli Markam, Consul General of Malaysia in Hong Kong SAR and Macao SAR; Philip Lim, Head of Equity Markets and Group Head of Equity Derivatives of Kenanga Investment Bank; Kenneth Teoh, Deputy Head of Equity Derivatives and Head of Equity Derivatives Trading; and Isabelle Zhen, Head of Group Equity Marketing

KUALA LUMPUR: Kenanga Investment Bank Bhd has announced the world's first structured warrants linked to the Hang Seng Biotech Index (HSBIO) under its flagship brand, NagaWarrants by Kenanga.

In a statement, it said the warrants, HSBIO-CAA (0661AA) and HSBIO-HBA (0661BA), provide Malaysian investors with exposure to Hong Kong’s biotechnology and healthcare sector, one of Asia’s most compelling long-term growth themes driven by demographic shifts, rising healthcare demand and continued medical innovation. 

The HSBIO tracks 30 of the largest biotechnology and healthcare companies listed in Hong Kong. The index, which gained 64.5% in 2025, outperformed other Hong Kong benchmarks, including the Hang Seng Index (HSI), Hang Seng China Enterprises Index (HSSCEI) and Hang Seng TECH Index (HSTECH). 

"This latest launch underscores our focus on delivering differentiated products that broaden investor choice and provide access to a wider range of market opportunities beyond traditional benchmarks,” said Datuk Chay Wai Leong, group managing director of Kenanga Investment Bank.

Philip Lim Kuok Wei, head of equity markets and group head of equity derivatives of Kenanga Investment Bank, added that HSBIO structured warrants provide investors with a familiar way to gain exposure to biotechnology.

"The addition of HSBIO-CAA and HSBIO-HBA broadens the range of Hong Kong market exposures available through NagaWarrants, complementing existing offerings linked to the HSI, HSCEI and HSTECH," he said.

 

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Kenanga IB , warrants , Hang Seng , Biotech

Next In Business News

HB Global unable to meet FY26 annual report deadline
TNB issues RM4.8bil sustainability sukuk wakalah under RM10bil sukuk programme
Dataprep executive chairman Wan Ahmad Rudirman resigns
Ringgit ends higher against major currencies, eases vs US$
Infomina gets RM32.11mil Home Ministry contract for JPN system maintenance
Ni Hsin proposes one-for-two bonus warrants
Agmo partners with MyDigital Corp to upskill Malaysians in AI
TNB pledges to connect approved data centres to the grid within one year
Impact Capital aims to raise RM21.27mil from IPO ahead of ACE Market listing
Bintai Kinden unit accepts TNB contract for RM20.28mil

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read